StageBio Acquires TPL Path Labs
October 21, 2020
StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.
- Buyers
- StageBio, Ampersand Capital Partners
- Targets
- TPL Path Labs (TPL Path Labs GmbH)
- Platforms
- StageBio
- Industry
- Healthcare Services
- Location
- Baden-Württemberg, Germany
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
US BioTek Laboratories Merges With NutriPATH Pathology
March 3, 2026
Healthcare Services
US BioTek Laboratories, a Seattle-based functional laboratory, has completed a strategic merger with Australian functional pathology provider NutriPATH Pathology based in Melbourne. The combined organization expands functional pathology and diagnostic testing capabilities and extends international access for healthcare providers, while NutriPATH continues operating under its established brand in Australia.
-
StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS
August 13, 2025
Medical Devices
StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.
-
StatLab Medical Products Acquires CellPath Ltd.
June 8, 2022
Medical Devices
StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.
-
SourceBio International plc Acquires LDPath Limited
March 29, 2022
Healthcare Services
SourceBio International plc has completed a strategic acquisition of LDPath Limited, a London-based digital pathology testing provider. The deal expands SourceBio's digital and AI-enabled pathology capabilities and creates a larger private provider of cellular and digital pathology services for the U.K. healthcare market.
-
Discovery Life Sciences Acquires Targos Molecular Pathology GmbH
May 18, 2021
Healthcare Services
Discovery Life Sciences has acquired Targos Molecular Pathology GmbH, a leading European molecular pathology laboratory, to expand its global tissue biomarker services. The deal integrates Targos's IHC and clinical-pathology capabilities with Discovery's North American labs and HudsonAlpha Discovery sequencing/bioinformatics capabilities to create a market-leading global tissue biomarker services division.
-
Synergy Laboratories Acquires Pathology Laboratory Associates
March 3, 2020
Healthcare Services
Synergy Laboratories, a Mobile, Alabama-based clinical laboratory, has acquired Mobile-based Pathology Laboratory Associates (PLA). The acquisition expands Synergy's pathology and women’s health testing capabilities, with PLA remaining headquartered on the Springhill Medical Center campus and plans to grow staffing and specialized pathology services.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.